Lung Transplant

Emphysema affects an estimated 60 million people worldwide. It is a disease associated with significant morbidity in the form of dyspnea and exercise limitation and mortality. The pathology behind this is the destruction of pulmonary parenchyma, both alveolar walls and interstitial tissue.